These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 25511758)
21. Use of Chronic Kidney Disease to Enhance Prediction of Cardiovascular Risk in Those at Medium Risk. Chia YC; Lim HM; Ching SM PLoS One; 2015; 10(10):e0141344. PubMed ID: 26496190 [TBL] [Abstract][Full Text] [Related]
22. Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health. Tomey MI; Winston JA Ann Glob Health; 2014; 80(1):69-76. PubMed ID: 24751567 [TBL] [Abstract][Full Text] [Related]
23. Role of oxidative stress on chronic kidney disease progression. Putri AY; Thaha M Acta Med Indones; 2014 Jul; 46(3):244-52. PubMed ID: 25348188 [TBL] [Abstract][Full Text] [Related]
24. The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder. Seifert ME; Hruska KA Transplantation; 2016 Mar; 100(3):497-505. PubMed ID: 26356179 [TBL] [Abstract][Full Text] [Related]
25. Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. Major RW; Cheng MRI; Grant RA; Shantikumar S; Xu G; Oozeerally I; Brunskill NJ; Gray LJ PLoS One; 2018; 13(3):e0192895. PubMed ID: 29561894 [TBL] [Abstract][Full Text] [Related]
26. [Cardiovascular Disease In Children With Ckd]. Corrado C; Pellitteri V; Alaimo A; Galione MA; Mongiovì R; Maringhini S G Ital Nefrol; 2015; 32(6):. PubMed ID: 26845213 [TBL] [Abstract][Full Text] [Related]
27. Antiplatelet effects of aspirin in chronic kidney disease patients. Polzin A; Dannenberg L; Sansone R; Levkau B; Kelm M; Hohlfeld T; Zeus T J Thromb Haemost; 2016 Feb; 14(2):375-80. PubMed ID: 26644261 [TBL] [Abstract][Full Text] [Related]
28. Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD Study. Matsui M; Uemura S; Takeda Y; Samejima K; Matsumoto T; Hasegawa A; Tsushima H; Hoshino E; Ueda T; Morimoto K; Okamoto K; Okada S; Onoue K; Okayama S; Kawata H; Kawakami R; Maruyama N; Akai Y; Iwano M; Shiiki H; Saito Y; J Am Soc Nephrol; 2015 Nov; 26(11):2871-81. PubMed ID: 25788536 [TBL] [Abstract][Full Text] [Related]
29. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Ricardo AC; Anderson CA; Yang W; Zhang X; Fischer MJ; Dember LM; Fink JC; Frydrych A; Jensvold NG; Lustigova E; Nessel LC; Porter AC; Rahman M; Wright Nunes JA; Daviglus ML; Lash JP; Am J Kidney Dis; 2015 Mar; 65(3):412-24. PubMed ID: 25458663 [TBL] [Abstract][Full Text] [Related]
30. Vitamin K intake and mortality in people with chronic kidney disease from NHANES III. Cheung CL; Sahni S; Cheung BM; Sing CW; Wong IC Clin Nutr; 2015 Apr; 34(2):235-40. PubMed ID: 24745600 [TBL] [Abstract][Full Text] [Related]
31. Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3. Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW Nephron Clin Pract; 2012; 122(1-2):58-65. PubMed ID: 23548499 [TBL] [Abstract][Full Text] [Related]
32. Predicting cardiovascular mortality in chronic kidney disease (CKD) patients. Sun W; Liu D; Gong P; Shi X; Wang Y; Wang P; Gong W Ann Transplant; 2014 Oct; 19():513-8. PubMed ID: 25315215 [TBL] [Abstract][Full Text] [Related]
33. Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy. Athyros VG; Tziomalos K; Karagiannis A Expert Rev Cardiovasc Ther; 2015; 13(9):1059-66. PubMed ID: 26206619 [TBL] [Abstract][Full Text] [Related]